Biofrontera Competitors and Similar CompaniesClear all
Skyepharma's competitors and similar companies include Affimed N.V..
 Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. | ||
Founding Date | Founding Date 1996 | Founding Date 2000 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Saint-Quentin-Fallavier, FR HQ | Locations Heidelberg, DE HQ |
Employees | Employees 2453% increase | Employees 76 |
Financial | ||
Revenue (est.) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) €8.3m (FY, 2023) |
Cost of goods | Cost of goods £43.1m (FY, 2015) | Cost of goods N/A |
Gross profit | Gross profit £52.8m (FY, 2015) | Gross profit €13m (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Affimed N.V.
HQ
Heidelberg, DE
Employees
76
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
View company